Who invested in Silverback Therapeutics?
Silverback Therapeutics's investors include Alexandria Real Estate Equities and OrbiMed/ Celegene.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$38Mraised across 1 round since 2018, from 1 source
Reported by GeekWireSEC filing: $12M sold, first sale Sept 2018
From Silverback Therapeutics's own website and the SEC filings it signed: 8 on the team.
On the board, as filediJonathan L. RootPeter A. ThompsonRobert L. HershbergSaqib L. IslamScott L. PlatshonThilo L. SchroederVickie L. Capps
Silverback Therapeutics's investors include Alexandria Real Estate Equities and OrbiMed/ Celegene.
Silverback Therapeutics has raised $38M across 1 round since 2018.
Silverback Therapeutics's most recent round was a Series A of $38M in Sept 2018.
Its most recent round, $38M in Sept 2018, is also its largest on record.
Silverback Therapeutics's first round on record, in Sept 2018, was backed by Alexandria Real Estate Equities and OrbiMed/ Celegene.
Silverback Therapeutics's latest named round is a Series A, in Sept 2018.
Silverback Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.